06/26 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Flex Pharma, Inc.
To join this class action, please complete the following Investor Certification. Oklahoma City, OK (June 26, 2018) – On June 19, 2018, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against Flex Pharma, Inc. (NASDAQ: FLKS). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is […]